Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Elevating Work Comp Care Through Physical Medicine Innovation
When it comes to physical therapy (PT), ensuring injured employees receive timely, effective care can be critical to recovery.
Workers' Comp
News Release
Enlyte’s 2025 Trends Report Examines ‘The Year of Generative AI’
Industry leaders discuss impact on the growing utilization of gen AI and data analytics as well as strategies addressing clinical and auto cha
Workers' Comp
Article
Specialty Solutions Spotlight: How Bone Growth Stimulators Accelerate Healing
Who is best suited to use a bone growth stimulator after an injury?Recovering from a broken bone can be a long and difficult journey, ofte
Workers' Comp
Article
Functional Capacity Evaluation (FCE) Frequently Asked Questions
What is a Functional Capacity Evaluation (FCE)?An FCE is a comprehensive assessment used to determine an individual's physical
Workers' Comp
Case Study
Clinical Oversight Reduces Claim Costs by Recommending Discharge Over Added PT
Workers' Comp
Article
Workers' Compensation Pharmacy Legislative and Regulatory End of Year Recap
New regulations, proposed legislation, and notable judicial developments made 2024 a significant year for workers' compensation pharmacy programs.